Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.
Denali Therapeutics is a Biotechnology company focused on Neurodegenerative Diseases. The headquarters is in USA.
Livongo Health is a Biotechnology company. The headquarters is in USA.
Teladoc which provides virtual doctors acquired Livongo in October-2020 for 18.5 Billion USD.
Teladoc which provides virtual doctors acquired Livongo in October-2020 for 18.5 Billion USD.
BGI Genomics is the leading provider of genomic sequencing services and proteomic services company. The company annual revenue is 1.5 billion USD and 3,585 employees as on 2020. The headquarters is in China.
LivaNova is a Medical Technology company. The company products and therapies are neuromodulation, resources and cardiovascular. It offers a diverse product portfolio with a differentiated pipeline and reach is broad with a presence in more than 100 countries and approximately 4,000 employees. The headquarters is in UK.
Myovant Sciences is a biopharmaceutical company. It works for women and for men through purpose driven science, Empowering Medicines and Transformative Advocacy company. It have three clinical programs for relugolix which consisted of five international phase 3 clinical trials, two in women with heavy menstrual bleeding associated with uterine fibroids, two in women with endometriosis associated pain and one in men with advanced prostate cancer. The headquarters is in UK.
Sumitovant Biopharma acquired Myovant Sciences for 1.7 billion USD in 2023.
Synthorx is a Clinical Stage Biotechnology company. It is focused on prolonging and improving the lives of people with cancer and autoimmune disorders and platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics referred to as Synthorins. The headquarters is in USA.
Assore delisted from JSE in March-2020.